SHUKLA SANJAY (President and CEO) sold 8.6% of their position (778.00 shares) of ATYR PHARMA INC on the open market
Open‑market sale worth $6.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/9/2021ACC: 0001209191-21-009112
Officer· President and CEO
Since Feb 2019
-778.00
Net shares
Net seller
$6.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.78K acquired · 2.56K disposed
Non-Derivative Transactions2
Common stock
Direct
Shares
+1.78K
Price / share
—
Trade value
—
% of position
24.5%
2/6/2021
7.29K→9.08K
Common stock
Direct
Shares
−778.00
Price / share
$7.66
Trade value
$5.96K
% of position
8.6%
2/9/2021
9.08K→8.30K
Total
Net shares
+1.01K
Net value
-$5.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 2/6/2021 | M · Option Exercise | +1.78K | — | — | 24.5% | 7.29K | 9.08K |
| Common stock Direct | 2/9/2021 | S · Sale | −778.00 | $7.66 | $5.96K | 8.6% | 9.08K | 8.30K |
| Total | +1.01K | -$5.96K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
1.78K shares
Shares
−1.78K
Strike price
Held after
0.00
Exercisable
—
2/6/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock1.78K shares | 2/6/2021 | M · Option Exercise | −1.78K | — | 0.00 |